A multicenter phase II study of vorinostat in patients (pts) with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (B-NHL) or mantle cell lymphoma (MCL).

被引：0

作者：

Ando, Kiyoshi

Ogura, Michinori

Suzuki, Tatsuya

Ishizawa, Kenichi

Oh, Sung Yong

Kim, Won Seog

Tanaka, Yoshinobu

Shimamoto, Takashi

Tobinai, Kensei

机构：

[1] Tokai Univ, Dept Hematol & Oncol, Hiratsuka, Kanagawa 25912, Japan

[2] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan

[3] Tohoku Univ Hosp, Sendai, Miyagi, Japan

[4] Dong A Univ, Coll Med, Dept Internal Med, Pusan, South Korea

[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea

[6] MSD KK, Tokyo, Japan

[7] Natl Canc Ctr, Tokyo, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8029

引用

页数：1